myotonic dystrophy
-
Harmony Biosciences Looking to Raise $100 Million in IPO to Study Key Ingredient in Wakix
Plymouth Meeting-based Harmony Biosciences, which markets the drug Wakix for patients with narcolepsy, is planning to raise $100 million with…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
